T-cell masthead image

Resources

Paper

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice

  • External Link
COVID-19: Lai, C.Y., To, A., Wong, T.A.S., Lieberman, M.M., Clements, D.E., Senda, J.T., Ball, A.H., Pessaint, L., Andersen, H., Donini, O., Lehrer, A.T. Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice. 2021.
Publication

Frontiers in Immunity CoVaccine HT™ Publication

  • External Link
COVID-19: Haun, B.K., Lai, C.Y., Williams, C.A., Wong, T.A.S., Lieberman, M.M., Pessaint, L., Andersen, H., Lehrer, A.T. CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. 2020.
Pre-Print

Endpoint and Epitope-specific Antibody Responses as Correlates of Vaccine-mediated Protection of Mice against Ricin Toxin

  • External Link
Greta Van Slyke, Dylan J Ehrbar, Jennifer Doering, Jennifer L. Yates, Ellen S.Vitetta, Oreola Donini, Nicholas J Mantis. Endpoint and Epitope-specific Antibody Responses as Correlates of Vaccine-mediated Protection of Mice against Ricin Toxin. BioRxiv. 2020.
Poster

Preservation of Quaternary Structure in Thermostable, Lyophilized Ebola Glycoprotein Vaccines

  • External Link
Preston, K.B., Monticello, C.R., Wong, T.A., Donini, O., Lehrer, A.T., Randolph, T.W. Preservation of Quaternary Structure in Thermostable, Lyophilized Ebola
Glycoprotein Vaccines. Poster presentation at the 2019 Colorado Protein Stability Conference. July 30-August 1, 2019.
Poster

Preliminary Stability Assays for a Thermostable, Trivalent Filovirus Vaccine

  • External Link
Preston, K.B., Monticello, C.R., Wong, T.A., Donini, O., Lehrer, A.T., Randolph, T.W. Preliminary Stability Assays for a Thermostable, Trivalent Filovirus Vaccine. Poster presentation at the 2019 Colorado Protein Stability Conference. July 30-August 1, 2019.
Publication

Dr. Christopher J. Schaber’s Interview with The Wall Street Analyzer

In this interview, Dr. Christopher J. Schaber, President and CEO, discusses the Company with The Wall Street Analyzer.
Paper

Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide

  • External Link
Ebola: Chisholm F, Kang JT, Dong M, Lewis K, Namekar M, Lehrer AT, Randolph TW. Thermostable Ebola Virus Vaccine Formulations Lyophilized in the Presence of Aluminum Hydroxide. Eur. J. Pharm. Bipharm. 2019. 136: 213-20.
Publication

Article in Drug Target Review

In this article in Drug Target Review, Drs. Donini, Schaber, and Straube discuss innate immunity.
Publication

Dr. Oreola Donini’s Interview with Nature

In this interview, Dr. Oreola Donini, Senior Vice President and Chief Scientific Officer, discusses innate immunity and development of Innate Defense Regulator technology with Nature.